Fifth Third Bancorp’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$44.5K Hold
2,500
﹤0.01% 1458
2025
Q1
$44.6K Hold
2,500
﹤0.01% 1464
2024
Q4
$74.5K Hold
2,500
﹤0.01% 1242
2024
Q3
$39.1K Hold
2,500
﹤0.01% 1525
2024
Q2
$42.8K Buy
+2,500
New +$42.8K ﹤0.01% 1431
2024
Q1
Sell
-1,000
Closed -$14.9K 2499
2023
Q4
$14.9K Sell
1,000
-254
-20% -$3.79K ﹤0.01% 1857
2023
Q3
$20.3K Sell
1,254
-750
-37% -$12.1K ﹤0.01% 1736
2023
Q2
$83.2K Buy
2,004
+1,000
+100% +$41.5K ﹤0.01% 1204
2023
Q1
$60.4K Sell
1,004
-2,231
-69% -$134K ﹤0.01% 1369
2022
Q4
$237K Buy
3,235
+896
+38% +$65.7K ﹤0.01% 893
2022
Q3
$178K Buy
2,339
+1,293
+124% +$98.4K ﹤0.01% 968
2022
Q2
$73K Hold
1,046
﹤0.01% 1231
2022
Q1
$87K Buy
1,046
+8
+0.8% +$665 ﹤0.01% 1238
2021
Q4
$78K Buy
1,038
+38
+4% +$2.86K ﹤0.01% 1324
2021
Q3
$116K Sell
1,000
-16
-2% -$1.86K ﹤0.01% 1127
2021
Q2
$225K Buy
1,016
+16
+2% +$3.54K ﹤0.01% 942
2021
Q1
$132K Sell
1,000
-2,921
-74% -$386K ﹤0.01% 1072
2020
Q4
$678K Buy
3,921
+1,270
+48% +$220K ﹤0.01% 621
2020
Q3
$295K Buy
2,651
+270
+11% +$30K ﹤0.01% 757
2020
Q2
$141K Buy
2,381
+1,218
+105% +$72.1K ﹤0.01% 984
2020
Q1
$78K Buy
1,163
+158
+16% +$10.6K ﹤0.01% 1132
2019
Q4
$85K Buy
1,005
+146
+17% +$12.3K ﹤0.01% 1215
2019
Q3
$64K Sell
859
-913
-52% -$68K ﹤0.01% 1277
2019
Q2
$112K Buy
1,772
+318
+22% +$20.1K ﹤0.01% 1095
2019
Q1
$70K Buy
1,454
+578
+66% +$27.8K ﹤0.01% 1170
2018
Q4
$29K Buy
876
+13
+2% +$430 ﹤0.01% 1415
2018
Q3
$45K Buy
863
+64
+8% +$3.34K ﹤0.01% 1351
2018
Q2
$25K Buy
+799
New +$25K ﹤0.01% 1581